Trending

Cancer Research UK

As cancer treatments evolve, so must investment mechanisms

As cancer treatments evolve, so must investment mechanisms

Last month’s American Society of Clinical Oncology (ASCO) meeting kicked off with a presentation from Professor Ruth Plummer,

X

As cancer treatments evolve, so must investment mechanisms

https://pharmaphorum.com/views-analysis-oncology/as-cancer-treatments-evolve-so-must-investment-mechanisms/

CRUK tests drug combo for advanced pancreatic cancer

CRUK tests drug combo for advanced pancreatic cancer

Cancer Research UK has announced it will study Plexxikon’s dual kinase inhibitor PLX7486 in combination with gemcitabine in

X

CRUK tests drug combo for advanced pancreatic cancer

https://pharmaphorum.com/news/cruk-tests-drug-combo-for-advanced-pancreatic-cancer/

Genetic test can predict efficacy of chemotherapy in breast cancer

Genetic test can predict efficacy of chemotherapy in breast cancer

Researchers have found that a genetic test can successfully predict whether chemotherapy would be beneficial for patients with

X

Genetic test can predict efficacy of chemotherapy in breast cancer

https://pharmaphorum.com/news/genetic-test-can-predict-efficacy-of-chemotherapy-in-breast-cancer/

CRUK and Owlstone launch trial for cancer breath test

CRUK and Owlstone launch trial for cancer breath test

Cancer Research UK and Owlstone Medical have launched a clinical trial to develop a breath test that could

X

CRUK and Owlstone launch trial for cancer breath test

https://pharmaphorum.com/news/cruk-and-owlstone-launch-trial-for-cancer-breath-test/

AstraZeneca looks to CRISPR to boost success rates

AstraZeneca looks to CRISPR to boost success rates

Between 2005 and 2010 AstraZeneca‘s success rates for taking drugs from candidate nomination to phase III completion were at 4%, below

X

AstraZeneca looks to CRISPR to boost success rates

https://pharmaphorum.com/views-and-analysis/astrazeneca-crispr-boost-success-rates/

AZ and CRUK team up to go all-in on CRISPR

AZ and CRUK team up to go all-in on CRISPR

AstraZeneca and Cancer Research UK are collaborating to launch a centre of excellence in genetic screening, cancer modelling

X

AZ and CRUK team up to go all-in on CRISPR

https://pharmaphorum.com/news/az-cruk-crispr/

Cancer Research UK gives $4m funding to Glasgow Uni CML project

Cancer Research UK gives $4m funding to Glasgow Uni CML project

Cancer Research UK granted £3.1m (nearly $4m) to a group of researchers at the University of Glasgow to

X

Cancer Research UK gives $4m funding to Glasgow Uni CML project

https://pharmaphorum.com/news/experimental-leukaemia-study-grant/

UK researchers trial new cancer immunotherapy

UK researchers trial new cancer immunotherapy

The charity Cancer Research UK has joined with Biotecnol to begin early-stage clinical trials of a new kind

X

UK researchers trial new cancer immunotherapy

https://pharmaphorum.com/news/uk-researchers-trial-new-cancer-immunotherapy/

CRUK launches next phase of cancer ‘Grand Challenge’

CRUK launches next phase of cancer ‘Grand Challenge’

Charity launches second set of research challenges.

X

CRUK launches next phase of cancer ‘Grand Challenge’

https://pharmaphorum.com/news/uk-charity-poses/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com